Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Summary
The primary goal of this study is to examine whether recurrence of HPV-associated OPSCC can be predicted by two factors: 1) mutations in genes called TRAF3 and CYLD, and 2) measurements of circulating HPV DNA in blood plasma. The study will also investigate whether HPV integration is associated with TRAF3 and CYLD mutations, and whether recurrence prediction improves when looking at HPV integration along with TRAF3 and CYLD mutations.
Official title: LCCC 2044: Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
220
Start Date
2020-11-19
Completion Date
2033-11
Last Updated
2025-04-27
Healthy Volunteers
No
Conditions
Locations (3)
Mayo Clinic
Rochester, Minnesota, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Trident Medical Center (HCA Healthcare )
North Charleston, South Carolina, United States